Stay updated on Nitazoxanide for Acute Influenza: Clinical Trial
Sign up to get notified when there's something new on the Nitazoxanide for Acute Influenza: Clinical Trial page.

Latest updates to the Nitazoxanide for Acute Influenza: Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov footer revision label updates from v3.8.0 to v3.8.1, with no apparent changes to the study record.SummaryDifference0.0%

- Check9 days agoChange DetectedThe clinical trial record for nitazoxanide, alone and with oseltamivir, is displayed, including its completed status, study design, eligibility criteria, outcome measures, and participating locations.SummaryDifference100%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedA banner announces an NIH-wide transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2 while the study record page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check44 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Nitazoxanide for Acute Influenza: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nitazoxanide for Acute Influenza: Clinical Trial page.